Seroconversion and neutralizing antibodies production after completion of <scp>Pfizer‐BioNTech BNT</scp> 162b2 vaccination scheme among psoriatic patients receiving biological or topical treatment: A prospective observational cohort study-Reference-Cited by-同舟云学术

Seroconversion and neutralizing antibodies production after completion of Pfizer‐BioNTech BNT 162b2 vaccination scheme among psoriatic patients receiving biological or topical treatment: A prospective observational cohort study

Published:2022-12-15 Issue:4 Volume:37 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Stinco Giuseppe¹²^ORCID,Errichetti Enzo¹²,Figini Matteo²,Guglielmo Alba²^ORCID,Fazzi Benedetta²,Quartuccio Luca¹³,Zabotti Alen³^ORCID,De Vita Salvatore¹³,Isola Miriam¹⁴,De Martino Maria⁴,Rossi Silvia¹,Lucis Riccardo¹,Fabris Martina⁵,Beltrami Antonio Paolo¹⁵,Curcio Francesco¹⁵,D'Aurizio Federica⁵

Affiliation:

1. Department of Medicine (DAME) University of Udine Udine Italy

2. Institute of Dermatology Azienda Sanitaria Universitaria Friuli Centrale (ASUFC) Udine Italy

3. Rheumatology Clinic Azienda Sanitaria Universitaria Friuli Centrale (ASUFC) Udine Italy

4. Division of Medical Statistics University of Udine Udine Italy

5. Institute of Clinical Pathology Azienda Sanitaria Universitaria Friuli Centrale (ASUFC) Udine Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18809

Reference8 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

2. The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study

3. Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors

4. Seroconversion after anti‐SARS‐CoV‐2 mRNA vaccinations among moderate‐to‐severe psoriatic patients receiving systemic biologicals – prospective observational cohort study;Piros ÉA;Dermatol Ther,2022

5. T-Cell and Antibody Responses to First BNT162b2 Vaccine Dose in Previously SARS-CoV-2-Infected and Infection-Naive UK Healthcare Workers: A Multicentre, Prospective, Observational Cohort Study